Seminars in Oncology
Volume 34, Issue 2 , Pages 98-109 , April 2007

Urinary Diversion: Options, Patient Selection, and Outcomes

  • Dipen J. Parekh
  • ,
  • S. Machele Donat

      Affiliations

    • Corresponding Author InformationAddress correspondence to S. Machele Donat, MD, FACS, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021.

References 

  1. Bricker EM. Bladder substitution with isolated small intestine segments; a progress report. Am Surg. 1952;18:654–664
  2. Atala A. Regeneration of urologic tissues and organs. Adv Biochem Eng Biotechnol. 2005;94:181–210
  3. Austin PF, DeLeary G, Homsy YL, et al. Long-term metabolic advantages of a gastrointestinal composite urinary reservoir. J Urol. 1997;158:1704–1707
  4. Lockhart JL, Davies R, Cox C, et al. The gastroileoileal pouch: An alternative continent urinary reservoir for patients with short bowel, acidosis and/or extensive pelvic radiation. J Urol. 1993;150:46–50
  5. Ravi R, Dewan AK, Pandey KK. Transverse colon conduit urinary diversion in patients treated with very high dose pelvic irradiation. Br J Urol. 1994;73:51–54
  6. Kato H, Igawa Y, Komiyama I, et al. Continent urinary reservoir formation with transverse colon for patients with pelvic irradiation. Int J Urol. 2002;9:200–203
  7. Mills RD, Studer UE. Metabolic consequences of continent urinary diversion. J Urol. 1999;161:1057–1066
  8. McDougal WS, Stampfer DS, Kirley S, et al. Intestinal ammonium transport by ammonium and hydrogen exchange. J Am Coll Surg. 1995;181:241–248
  9. Stampfer DS, McDougal WS. Inhibition of the sodium/hydrogen antiport by ammonium ion. J Urol. 1997;157:362–365
  10. Koch MO, Gurevitch E, Hill DE, et al. Urinary solute transport by intestinal segments: A comparative study of ileum and colon in rats. J Urol. 1990;143:1275–1279
  11. Boyd SD, Schiff WM, Skinner DG, et al. Prospective study of metabolic abnormalities in patient with continent Kock pouch urinary diversion. Urology. 1989;33:85–88
  12. Koch MO, McDougal WS. Chlorpromazine: Adjuvant therapy for the metabolic derangements created by urinary diversion through intestinal segments. J Urol. 1985;134:165–169
  13. Koch MO, McDougal WS. Nicotinic acid: treatment for the hyperchloremic acidosis following urinary diversion through intestinal segments. J Urol. 1985;134:162–164
  14. Thompson WG, Wrathell E. The relation between ileal resection and vitamin B12 absorption. Can J Surg. 1977;20:461–464
  15. Filipsson S, Hulten L, Lindstedt G. Malabsorption of fat and vitamin B12 before and after intestinal resection for Crohn’s disease. Scand J Gastroenterol. 1978;13:529–536
  16. Gosalbez R, Woodard JR, Broecker BH, et al. Metabolic complications of the use of stomach for urinary reconstruction. J Urol. 1993;150:710–712
  17. Nguyen DH, Bain MA, Salmonson KL, et al. The syndrome of dysuria and hematuria in pediatric urinary reconstruction with stomach. J Urol. 1993;150:707–709
  18. Plawker MW, Rabinowitz SS, Etwaru DJ, et al. Hypergastrinemia, dysuria-hematuria and metabolic alkalosis: complications associated with gastrocystoplasty. J Urol. 1995;154:546–549
  19. Klein EA, Montie JE, Montague DK, et al. Jejunal conduit urinary diversion. J Urol. 1986;135:244–246
  20. Koch MO, McDougal WS, Thompson CO. Mechanisms of solute transport following urinary diversion through intestinal segments: An experimental study with rats. J Urol. 1991;146:1390–1394
  21. Koch MO, McDougal WS, Flora MD. Urease and the acidosis of urinary intestinal diversion. J Urol. 1991;146:458–462
  22. McDougal WS, Koch MO. Accurate determination of renal function in patients with intestinal urinary diversions. J Urol. 1986;135:1175–1178
  23. Kaveggia FF, Thompson JS, Schafer EC, et al. Hyperammonemic encephalopathy in urinary diversion with urea-splitting urinary tract infection. Arch Intern Med. 1990;150:2389–2392
  24. Adams MC, Mitchell ME, Rink RC. Gastrocystoplasty: an alternative solution to the problem of urological reconstruction in the severely compromised patient. J Urol. 1988;140:1152–1156
  25. Steven K, Poulsen AL. The orthotopic Kock ileal neobladder: Functional results, urodynamic features, complications and survival in 166 men. J Urol. 2000;164:288–295
  26. Stein JP, Grossfeld GD, Freeman JA, et al. Orthotopic lower urinary tract reconstruction in women using the Kock ileal neobladder: Updated experience in 34 patients. J Urol. 1997;158:400–405
  27. Parekh DJ, Gilbert WB, Smith JA. Functional lower urinary tract voiding outcomes after cystectomy and orthotopic neobladder. J Urol. 2000;163:56–58
  28. Puppo P, Introini C, Calvi P, et al. Prevention of chronic urinary retention in orthotopic bladder replacement in the female. Eur Urol. 2005;47:674–678
  29. Stein JP, Ginsberg DA, Skinner DG. Indications and technique of the orthotopic neobladder in women. Urol Clin North Am. 2002;29:725–734
  30. Elmajian DA, Stein JP, Esrig D, et al. The Kock ileal neobladder: Updated experience in 295 male patients. J Urol. 1996;156:920–925
  31. Colwell JC, Fichera A. Care of the obese patient with an ostomy. J Wound Ostomy Continence Nurs. 2005;32:378–383
  32. Hassan JM, Cookson MS, Smith JA, et al. Assessing intraoperative factors that prevent orthotopic urinary diversion in patients undergoing radical cystectomy. J Urol. 2005;(abstr 1122)
  33. Stenzl A, Bartsch G, Rogatsch H. The remnant urothelium after reconstructive bladder surgery. Eur Urol. 2002;41:124–131
  34. Schellhammer PF, Whitmore WF. Transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer. J Urol. 1976;115:56–60
  35. Tobisu K, Tanaka Y, Mizutani T, et al. Transitional cell carcinoma of the urethra in men following cystectomy for bladder cancer: multivariate analysis for risk factors. J Urol. 1991;146:1551–1553
  36. Levinson AK, Johnson DE, Wishnow KI. Indications for urethrectomy in an era of continent urinary diversion. J Urol. 1990;144:73–75
  37. Freeman JA, Tarter TA, Esrig D, et al. Urethral recurrence in patients with orthotopic ileal neobladders. J Urol. 1996;156:1615–1619
  38. Lebret T, Herve JM, Barre P, et al. Urethral recurrence of transitional cell carcinoma of the bladder (Predictive value of preoperative latero-montanal biopsies and urethral frozen sections during prostatocystectomy). Eur Urol. 1998;33:170–174
  39. Donat SM, Wei DC, McGuire MS, et al. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. J Urol. 2001;165:1580–1584
  40. Donat SM, Genega EM, Herr HW, et al. Mechanisms of prostatic stromal invasion in patients with bladder cancer: Clinical significance. J Urol. 2001;165:1117–1120
  41. Stein JP, Esrig D, Freeman JA, et al. Prospective pathologic analysis of female cystectomy specimens: Risk factors for orthotopic diversion in women. Urology. 1998;51:951–955
  42. Stenzl A, Colleselli K, Poisel S, et al. Anterior exenteration with subsequent ureteroileal urethrostomy in females (Anatomy, risk of urethral recurrence, surgical technique, and results). Eur Urol. 1998;33(suppl 4):18–20
  43. Stenzl A, Draxl H, Posch B, et al. The risk of urethral tumors in female bladder cancer: Can the urethra be used for orthotopic reconstruction of the lower urinary tract?. J Urol. 1995;153:950–955
  44. Maralani S, Wood DP, Grignon D, et al. Incidence of urethral involvement in female bladder cancer: An anatomic pathologic study. Urology. 1997;50:537–541
  45. Hautmann RE, Simon J. Ileal neobladder and local recurrence of bladder cancer: Patterns of failure and impact on function in men. J Urol. 1999;162:1963–1966
  46. Srinivas S, Mahalati K, Freiha FS. Methotrexate tolerance in patients with ileal conduits and continent diversions. Cancer. 1998;82:1134–1136
  47. Bulbul MA, Wazzan W, Farhat W, et al. Feasibility of radiation and chemotherapy following cystectomy and orthotopic neobladder for invasive bladder cancer. Can J Urol. 1998;5:469–471
  48. Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349:859–866
  49. Millikan R, Dinney C, Swanson D, et al. Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol. 2001;19:4005–4013
  50. Gheiler EL, Wood DP, Montie JE, et al. Orthotopic urinary diversion is a viable option in patients undergoing salvage cystoprostatectomy for recurrent prostate cancer after definitive radiation therapy. Urology. 1997;50:580–584
  51. Bochner BH, Figueroa AJ, Skinner EC, et al. Salvage radical cystoprostatectomy and orthotopic urinary diversion following radiation failure. J Urol. 1998;160:29–33
  52. Chang SS, Alberts GL, Smith JA, et al. Ileal conduit urinary diversion in patients with previous history of abdominal/pelvic irradiation. World J Urol. 2004;22:272–276
  53. Ahlstrand C, Herder A. Primary adenocarcinoma of distal ileum used as outlet from a right colonic urinary reservoir. Scand J Urol Nephrol. 1998;32:70–72
  54. Albertini JJ, Sujka SK, Helal MA, et al. Adenocarcinoma in a continent colonic urinary reservoir. Urology. 1998;51:499–500
  55. Turnbull RB. Intestinal stomas. Surg Clin North Am. 1958;38:1361–1372
  56. Hautmann RE. Urinary diversion: Ileal conduit to neobladder. J Urol. 2003;169:834–842
  57. Ali-el-Dein B, el-Sobky E, Hohenfellner M, et al. Orthotopic bladder substitution in women: Functional evaluation. J Urol. 1999;161:1875–1880
  58. Blute ML, Gburek BM. Continent orthotopic urinary diversion in female patients: Early Mayo Clinic experience. Mayo Clin Proc. 1998;73:501–507
  59. Killeen KP, Libertino JA. Management of bowel and urinary tract complications after urinary diversion. Urol Clin North Am. 1988;15:183–194
  60. Madersbacher S, Schmidt J, Eberle JM, et al. Long-term outcome of ileal conduit diversion. J Urol. 2003;169:985–990
  61. Perimenis P, Burkhard FC, Kessler TM, et al. Ileal orthotopic bladder substitute combined with an afferent tubular segment: Long-term upper urinary tract changes and voiding pattern. Eur Urol. 2004;46:604–609
  62. Farnham SB, Cookson MS. Surgical complications of urinary diversion. World J Urol. 2004;22:157–167
  63. Jahnson S, Pedersen J. Cystectomy and urinary diversion during twenty years—Complications and metabolic implications. Eur Urol. 1993;24:343–349
  64. Morales P, Golimbu M. Colonic urinary diversion: 10 years of experience. J Urol. 1975;113:302–307
  65. Holmes DG, Thrasher JB, Park GY, et al. Long-term complications related to the modified Indiana pouch. Urology. 2002;60:603–606
  66. Webster C, Bukkapatnam R, Seigne JD, et al. Continent colonic urinary reservoir (Florida pouch): long-term surgical complications (greater than 11 years). J Urol. 2003;169:174–176
  67. Parekh DJ, Gilbert WB, Koch MO, et al. Continent urinary reconstruction versus ileal conduit: A contemporary single-institution comparison of perioperative morbidity and mortality. Urology. 2000;55:852–855
  68. Rowland R. Neobladder: Reoperation or Percutaneous Intervention Rates for Complications. AUA Update Series. 1995;
  69. Rowland RG. The long-term study of continent cutaneous urinary reservoirs and neobladders. J Urol. 1996;155:1217
  70. Santucci RA, Park CH, Mayo ME, et al. Continence and urodynamic parameters of continent urinary reservoirs: Comparison of gastric, ileal, ileocolic, right colon, and sigmoid segments. Urology. 1999;54:252–257
  71. Sumfest JM, Burns MW, Mitchell ME. The Mitrofanoff principle in urinary reconstruction. J Urol. 1993;150:1875–1877
  72. Bihrle R. The Indiana pouch continent urinary reservoir. Urol Clin North Am. 1997;24:773–779
  73. Steers WD. Voiding dysfunction in the orthotopic neobladder. World J Urol. 2000;18:330–337
  74. Gerharz EW, Mansson A, Hunt S, et al. Quality of life after cystectomy and urinary diversion: An evidence based analysis. J Urol. 2005;174:1729–1736
  75. Nabi G, Yong SM, Ong E, et al. Is orthotopic bladder replacement the new gold standard? (Evidence from a systematic review). J Urol. 2005;174:21–28
  76. Hardt J, Filipas D, Hohenfellner R, et al. Quality of life in patients with bladder carcinoma after cystectomy: First results of a prospective study. Qual Life Res. 2000;9:1–12
  77. Parkinson JP, Konety BR. Health related quality of life assessments for patients with bladder cancer. J Urol. 2004;172:2130–2136
  78. Porter MP, Penson DF. Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: A systematic review and critical analysis of the literature. J Urol. 2005;173:1318–1322
  79. Cookson MS, Dutta SC, Chang SS, et al. Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder: Development and validation of a new disease specific questionnaire. J Urol. 2003;170:1926–1930
  80. Aragona F, De Caro R, Parenti A, et al. Structural and ultrastructural changes in ileal neobladder mucosa: A 7-year follow-up. Br J Urol. 1998;81:55–61
  81. Pickard R. Tumour formation within intestinal segments transposed to the urinary tract. World J Urol. 2004;22:227–234
  82. Azimuddin K, Khubchandani IT, Stasik JJ, et al. Neoplasia after ureterosigmoidostomy. Dis Colon Rectum. 1999;42:1632–1638
  83. Fichtner J. Follow-up after urinary diversion. Urol Int. 1999;63:40–45
  84. Gburek BM, Lieber MM, Blute ML. Comparison of studer ileal neobladder and ileal conduit urinary diversion with respect to perioperative outcome and late complications. J Urol. 1998;160:721–723
  85. Shimogaki H, Okada H, Fujisawa M, et al. Long-term experience with orthotopic reconstruction of the lower urinary tract in women. J Urol. 1999;161:573–577
  86. Mills RD, Studer UE. Female orthotopic bladder substitution: A good operation in the right circumstances. J Urol. 2000;163:1501–1504
  87. Hautmann RE, de Petriconi R, Gottfried HW, et al. The ileal neobladder: Complications and functional results in 363 patients after 11 years of followup. J Urol. 1999;161:422–427
  88. Studer UE, Zingg EJ. Ileal orthotopic bladder substitutes (What we have learned from 12 years’ experience with 200 patients). Urol Clin North Am. 1997;24:781–793

PII: S0093-7754(06)00487-8

doi: 10.1053/j.seminoncol.2006.12.010

Seminars in Oncology
Volume 34, Issue 2 , Pages 98-109 , April 2007